Patent details

EP2382977 Title: Therapeutic agents targeting the ncca-atp channel and methods of use thereof

Basic Information

Publication number:
EP2382977
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100107523
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Therapeutic agents targeting the ncca-atp channel and methods of use thereof
French Title of Invention:
Agents thérapeutiques ciblant le canal ncca-atp et procédés d'utilisation associés
German Title of Invention:
Therapeutische Mittel zum Targeting des NCCA-ATP-Kanals und Verwendungsverfahren dafür
SPC Number:

Dates

Filing date:
16/09/2005
Grant date:
06/08/2014
EP Publication Date:
06/08/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/11/2011
EP B1 Publication Date:
06/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/09/2014
Expiration date:
16/09/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/09/2005
 
 

Name:
The United States of America as represented
Address:
Department of Veterans Affairs Office of General Counsel -, Washington, DC 20420, United States (US)

Name:
University of Maryland Baltimore
Address:
Office of Research and Development 620 W. Lexington Street,, Baltimore, MD 21201, United States (US)

Inventor

Name:
Simard Marc J.
Address:
United States (US)

Priority

1

Priority Number:
610758 P
Priority Date:
18/09/2004
Priority Country:
United States (US)

2

Priority Number:
698272 P
Priority Date:
11/07/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61P 25/00;
Filing date Document type Number of pages